[1205] Diagnostic Markers in the Differentiation of Gynecologic and Urological Clear Cell Carcinoma

RJ Wolsky, E Lengyel, AG Montag. University of Chicago, Chicago

Background: The clear cell carcinoma (CCC) phenotype includes tumors from various sites with optically clear cytoplasm containing glycogen or lipid. CCC of the gynecologic tract is relatively common, including ovary, endometrium, cervix and vagina in descending order. Although CCC of the bladder and urethra are rare, differentiation from direct extension of a gynecologic tumor is important for appropriate staging and therapy. The present study analyzes markers of potential utility in differentiating CCC of the gynecologic and genitourinary tract.
Design: With IRB approval, archival slides and blocks were retrieved and tissue microarrays were designed containing CCC tumors from ovary (20), endometrium (21), cervix (15), vagina (4) bladder (3), urethra (3), kidney (17) and control tissues. Five micron sections were stained using monoclonal antibodies to E cadherin, alpha methyl co-A racemase (P504S), mesothelin, PLAP, uroplakin, CD10, and cytokeratins (CK) 7, 19 and 20. Staining intensity was visually scored by two observers on a scale of 0 to 3. Statistical analysis was performed using the Fisher exact test.
Results: All 6 bladder and urethral tumors had strong expression of E cadherin (see table), significantly greater than gynecologic sites or kidney (p<.01 for all comparisons). P504S was absent or weak in all cervical and vaginal tumors, while strong in 4 of 6 bladder/urethral lesions (p<.01). Only 1 of 6 bladder and urethral tumors was strongly positive for CK19, significantly less than gynecologic sites (p<.05 for all comparisons). CK7 (2/17) was less commonly and CD10 (12/17) more commonly expressed in renal CCC than in all other sites (p<.001 and p<.005 respectively). Few tumors of any type expressed CK20. Urologic tumors rarely expressed uroplakin (1/6 and 1/16 respectively) and PLAP and mesothelin showed no significant difference among any of the comparisons.

Staining intensity (number of cases)
E cadherinP504SCK19
Stain intensity0 to 12 to 30 to 12 to 30 to 12 to 3
Ovarian127136910
Endometrial154127910
Cervical/vaginal144180513
Bladder/urethral062451
Renal152107161



Conclusions: E cadherin, P504S and CK19 are useful in the differentiation of clear cell carcinoma of bladder or urethra from gynecologic sites, particularly cervical and vaginal lesions. CK7 and CD 10 have utility in differentiating renal cell carcinoma from other clear cell carcinomas.
Category: Gynecologic & Obstetrics

Wednesday, March 24, 2010 1:00 PM

Poster Session VI # 175, Wednesday Afternoon

 

Close Window